Type 2 diabetes and painful diabetic peripheral neuropathy research hub

Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) once weekly versus placebo in participants with type 2 diabetes and painful diabetic peripheral neuropathy

This clinical trial is testing a new once-weekly injection called CagriSema for adults with type 2 diabetes who experience nerve pain. Researchers want to find out if combining two medicines (cagrilintide and semaglutide) can safely ease nerve pain while improving blood sugar control and overall health.